Absolutely! Vegenics now 100% owned by CIR, storming ahead, a significant announcement this morning that seems to have been ignored by the market.
This and AAH are two that I really like, have a big chunk of both in my portfolio, and I'm as confident as I can be that they will pay off big time, long term.
As always with drug development though, patience is required.